. 2014 Jul 15;46(3):234–242. doi: 10.4143/crt.2014.46.3.234
Copyright © 2014 by the Korean Cancer Association
This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Fig. 1.
Plasma concentration-time curves of paclitaxel at each dose level.